Gitvin Remedies (GR) Private Limited

Gitvin Remedies (GR) Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24239GJ2020PTC111845 Incorporated 02 January 2020 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma Startup India MSME · Micro
Data last updated
Revenue · FY 2025
₹54.53 Lakh
▼ 36% YoY
Net profit · FY 2025
₹1.51 Lakh
Net margin 2.8%
EBITDA · FY 2025
₹2.47 Lakh
EBITDA margin 4.5%
Authorised capital
₹16 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Gitvin Remedies (GR) Private Limited

Data last updated:

Gitvin Remedies (GR) Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2020PTC111845. Its GSTIN is 24AAICG1606M1ZN (Gujarat).

The company has an authorised share capital of ₹16 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Gitvin Remedies Private Limited and Aspirom Bioscience Private Limited. It is led by directors Dhavalkumar Bharatkuamr Parmar and Bharatkumar Chhotalal Parmar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 805 Samudra Opp Shantanu Tower Sardar Patel Nagar Road Navrangpura, Ahmedabad, Gujarat, India – 380009.

As per the financials filed for FY 2025, the company reported a revenue of ₹54.53 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Lakh (net margin 2.8%) and EBITDA of ₹2.47 Lakh (EBITDA margin 4.5%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years.

The company is associated with 1 brand: Gitvin Remedies.

Gitvin Remedies (GR) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0004868). For more details, the company can be reached via its website gitvinremedies.com.

Company details

CIN U24239GJ2020PTC111845
Registration Number 111845
Incorporation Date 02 January 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0004868

Name history

Gitvin Remedies (GR) has undergone 4 name changes throughout its history. The current legal name is Gitvin Remedies (Gr) Private Limited.

Company NameStatus
Gitvin Remedies (GR) Private LimitedCurrent
Gitvin Remedies Private LimitedPrevious
Aspirom Bioscience Private LimitedPrevious
Dream Infrastructure Private LimitedPrevious

Recognitions & Rankings of Gitvin Remedies (GR)

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-GJ-01-0004868

Contact details

Gitvin Remedies (GR) Private Limited's registered office is in Ahmedabad, Gujarat. Its website is gitvinremedies.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    B – 805 Samudra Opp Shantanu Tower Sardar Patel Nagar Road Navrangpura, Ahmedabad, Gujarat, India – 380009
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Gitvin Remedies (GR) Private Limited, buy the company report.

Comprehensive company report
Gitvin Remedies (GR) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Gitvin Remedies (GR) operates one associated brand: Gitvin Remedies. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing, PCD franchise, and contract services in India.gitvinremedies.com

Business activity

The main business activity of Gitvin Remedies (GR) is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Gitvin Remedies (GR) Private Limited, buy the company report.

Financials of Gitvin Remedies (GR) Private Limited

FY 2025 filings available

Gitvin Remedies (GR) Private Limited reported revenue of ₹54.53 Lakh (down 36% YoY) for FY 2025.

Revenue · FY 2025
₹54.53 Lakh ▼ 36%
Net profit · FY 2025
₹1.51 Lakh margin 2.8%
EBITDA · FY 2025
₹2.47 Lakh margin 4.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 26%
EBITDA CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 43%

Revenue has declined at a compounded annual rate (CAGR) of 26% over three years, including a 36% fall in the latest year. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.47 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.51 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.5%
Net Profit Margin2.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gitvin Remedies (GR) Private Limited, buy the company report.

Board of directors of Gitvin Remedies (GR) Private Limited

Gitvin Remedies (GR) has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Dhavalkumar Bharatkuamr ParmarDirector02 Jan 20206 Years 9 MonthsCurrent
Bharatkumar Chhotalal ParmarAdditional Director16 Oct 20251 Years 0 MonthsCurrent

Peer comparison

Gitvin Remedies (GR) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Medzelon Pharmaceutical Private Limited₹54.59 Lakh (FY 2024)30.0%Kamrup Metropolitan, Assam, India
Gitvin Remedies (GR) Private Limitedthis company₹54.53 Lakh (FY 2025)₹1.51 Lakh2.8%-36.0%Ahmedabad, Gujarat, India
Qualis Health Care Formulations Private Limited₹54.28 Lakh (FY 2017)-25.0%Kozhikode, Kerala, India
Riobliss Life Sciences Private Limited₹54.04 Lakh (FY 2025)48.0%Greater Noida, Uttar Pradesh, India

To see the full peer comparison of Gitvin Remedies (GR) Private Limited, buy the company report.

Auditor

Gitvin Remedies (GR) Private Limited is audited by Fenil P. Shah & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Fenil P. Shah & AssociatesFY 2023143571W

Shareholding

The shareholding of Gitvin Remedies (GR) Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Gitvin Remedies (GR) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gitvin Remedies (GR) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Gitvin Remedies (GR) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAICG1606M1ZNGujaratActive17 Mar 2020

To see the full GST registrations and return filing status of Gitvin Remedies (GR) Private Limited, buy the company report.

Recent activity

Gitvin Remedies (GR) Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Bharatkumar Chhotalal Parmar was appointed as Additional Director on 16 Oct 2025.

Appointed
Bharatkumar Chhotalal Parmar was appointed as Additional Director.
AGM
Gitvin Remedies (Gr) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Jigar Kiranbhai Chauhan ceased to be Director.
Ceased
Ronak Kanubhai Chauhan ceased to be Additional Director.
Filing
Gitvin Remedies (Gr) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Dhavalkumar Bharatkuamr Parmar was appointed as Director.
Incorporation
02 Jan 2020
Gitvin Remedies (Gr) Private Limited was registered on 02 Jan 2020 with Roc Ahmedabad & aged 6 years 10 months as per MCA records.

Frequently asked questions

Gitvin Remedies (GR) is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2020 (6+ years old) and is registered under CIN U24239GJ2020PTC111845.

Gitvin Remedies (GR) has 2 current directors:

The latest financial statements of Gitvin Remedies (GR) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Gitvin Remedies (GR) is 24AAICG1606M1ZN, registered in Gujarat.

The CIN (Corporate Identification Number) of Gitvin Remedies (GR) is U24239GJ2020PTC111845. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gitvin Remedies (GR) was incorporated on 02 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Gitvin Remedies (GR) by revenue are Medzelon Pharmaceutical Private Limited, Qualis Health Care Formulations Private Limited, Riobliss Life Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Bharatkumar Chhotalal Parmar was appointed as Additional Director on 16 Oct 2025. Jigar Kiranbhai Chauhan ceased to be Director on 25 Aug 2025. Ronak Kanubhai Chauhan ceased to be Additional Director on 01 Aug 2025. Gitvin Remedies (GR) has 4 board changes on record in total.

Yes, Gitvin Remedies (GR) is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Gitvin Remedies (GR) is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0004868).

Gitvin Remedies (GR) can be reached through the website gitvinremedies.com. Its registered office is in Ahmedabad, Gujarat, India.